Abstract A038: Antigen Presentation By Cancer-Associated Fibroblasts
Abstract Introduction: Immunotherapy has shown promise in treating some patients with metastatic diseases, but the effectiveness of the immune system in controlling cancer is hampered by a suppressive tumor microenvironment (TME), in which cancer-associated fibroblasts (CAFs) play a key role. Developing new and highly specific immunotherapeutic tools targeting CAFs may have a significative impact on tumor control. For this purpose, we aim to investigate antigen presentation characteristics by MHC-I molecules in CAFs and identify targetable CAF-specific antigens. Methods and Results: Analysis of existing single-cell datasets revealed higher expression of MHC-I in CAFs compared to normal fibroblasts (p<0.05) in various tumor types. In melanoma, higher MHC-I expression was linked to resistance to immune checkpoint blockade (ICB). Additionally, we found a positive correlation between MHC-I expression and immunosuppressive molecules such as galectin-9 and HVEM. These observations were supported by initial flow cytometry analyses in CAF cell lines derived from patients. Furthermore, prolonged and severe hypoxia further elevated MHC-I protein levels in CAF cell lines. Using a proteogenomic approach with mass spectrometry, we identified over 10,000 antigens in five patient-derived CAF cell lines from primary breast cancer tumors and one normal fibroblast cell line. By integrating single-cell and bulk RNA sequencing data from various tumors and normal tissues, we identified more than 20 CAF-specific or fibroblast-specific antigens. Conclusion: CAFs exhibit high MHC-I expression, which is amplified under hypoxic conditions. We have identified CAF-specific antigens that require evaluation for their immunogenicity, indicating the potential of CAFs as targets for antigen-based therapies. Citation Format: Eralda Kina, Caroline Côté, Jean-David Larouche, Chantal Durette, Joel Lanoix, Eric Bonneil, Jean-Philippe Laverdure, Gabriel Ouellet Lavallée, Margaret Buchanan, Adriana , Fatima Mechta-Grigoriou, Pierre Thibault, Mark Basik, Claude Perreault. Antigen Presentation By Cancer-Associated Fibroblasts [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl):Abstract nr A038.
Authors
- Chantal Durette (ORCID: https://orcid.org/0000-0002-6692-1262)
- Pierre Thibault (ORCID: https://orcid.org/0000-0001-5993-0331)
- Adriana Aguilar (ORCID: https://orcid.org/0000-0003-2744-1220)
- Joël Lanoix (ORCID: https://orcid.org/0000-0001-7073-9298)
- Eralda Kina (ORCID: https://orcid.org/0000-0001-6191-7523)
- Gabriel Ouellet Lavallée
- Mark Basik (ORCID: https://orcid.org/0000-0002-2633-5410)
- Claude Perreault (ORCID: https://orcid.org/0000-0001-9453-7383)
- Jean‐David Larouche (ORCID: https://orcid.org/0000-0003-3056-0714)
- Éric Bonneil (ORCID: https://orcid.org/0000-0002-4039-3131)
- Jean‐Philippe Laverdure (ORCID: https://orcid.org/0000-0002-9245-6413)
- Caroline Côté (ORCID: https://orcid.org/0000-0002-2623-9808)
- Margaret Buchanan
- Fatima Mechta-Grigoriou
Institutions
- The Francis Crick Institute (GB)
- Jewish General Hospital (CA)
- Institute for Research in Immunology and Cancer (CA)
- Université de Montréal (CA)
- Institut Curie (FR)
Publication Details
- Journal
- Cancer Immunology Research
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1158/2326-6074.tumimm24-a038
- Primary Topic
- Medical Imaging and Pathology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00